Speaker illustration

Professor Hiroaki Shimokawa

Tohoku University, Sendai (Japan)

Member of:

European Society of Cardiology

Dr. Shimokawa is Professor and the Chairman of the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Dr. Shimokawa graduated from Kyushu University in 1979, obtained PhD degree in 1985, and has been appointed for the present position in 2005. In addition, he was appointed as the president of the Tohoku University Medical Association in 2012, the director of Clinical Research Institute of Tohoku University Hospital in 2013, and as the director of the Big Data Medicine Center of Tohoku University in 2017. His research projects include (1) molecular mechanisms of coronary artery spasm and atherosclerosis, (2) endothelial function, (3) development of innovative medical therapies, and (4) large clinical trials of heart failure and ischemic heart disease. He is well known for the development of animal models of coronary spasm (Science 1983) and the identification of endothelium-derived hydrogen peroxide as an important endothelium-derive

Functional coronary disease in patients with acute coronary syndromes

Event: ESC Congress 2019

Topic: Pathophysiology and Mechanisms

Session type: Moderated Posters

Thumbnail

Takotsubo: an acute heart failure syndrome

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiomyopathy

Session type: Symposium

Thumbnail

Physiology of stenting from bench to bedside

Event: ESC Congress 2016

Topic: Vulnerable plaque

Session type: Moderated Posters

Thumbnail

Environment and cardiovascular diseases

Event: ESC Congress 2016

Topic: Environment and CV diseases

Session type: Symposium

Thumbnail

Relationship between endothelial dysfunction, the microcirculation and myocardial ischaemia

Event: ESC Congress 2016

Topic: Endothelial function

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb